What are the recommended assessment and management steps for a 22‑year‑old with new‑onset anxiety?

Management of New-Onset Anxiety in a 22-Year-Old

For a 22-year-old with new-onset anxiety, begin with a structured assessment to identify symptom severity and rule out medical causes, then offer cognitive-behavioral therapy (CBT) as first-line treatment for mild-to-moderate symptoms, or combine CBT with an SSRI (such as sertraline or escitalopram) for moderate-to-severe presentations.

Initial Assessment Approach

Start by systematically screening using the GAD-7 (Generalized Anxiety Disorder-7 scale), which is the recommended validated tool for identifying anxiety symptoms 1, 2. This takes minutes to administer and provides a severity score that guides your next steps.

During your clinical interview, specifically identify:

• Physical manifestations: panic attacks, trembling, sweating, rapid breathing, tachycardia, palpitations, sweaty palms 3, 2
• Cognitive symptoms: excessive worry about multiple life domains (not just one area), difficulty controlling worry, fear disproportionate to actual risk 2
• Functional impairment: problems at work, school, relationships, or daily activities 1, 2
• Duration and pattern: symptoms present for at least 6 months for GAD; sudden onset may suggest panic disorder 1
• Safety concerns: any suicidal ideation, self-harm thoughts, or risk to others requires immediate psychiatric referral 3, 2

Rule Out Medical and Substance Causes

Before diagnosing an anxiety disorder, you must exclude:

• Medical conditions: hyperthyroidism, cardiac arrhythmias, hypoglycemia, respiratory disorders, neurological conditions 3, 2
• Substance-induced anxiety: caffeine excess, stimulant medications, cannabis, alcohol withdrawal, cocaine or amphetamine use 3, 2
• Medication side effects: corticosteroids, bronchodilators, thyroid medications 3

Order appropriate laboratory tests based on clinical suspicion (TSH, CBC, metabolic panel, urine drug screen if indicated).

Treatment Algorithm Based on Severity

Mild Anxiety (GAD-7 score 5-9)

Start with low-intensity interventions 3:

• Psychoeducation: Explain the physiological basis of anxiety, normalize the experience, discuss the relationship between thoughts, physical sensations, and behaviors
• Active monitoring: Schedule follow-up in 2-4 weeks to reassess symptoms
• Guided self-help: Provide structured CBT-based self-help materials or computerized CBT programs 4
• Supportive care: Address specific stressors, problem-solving for life circumstances 3

Moderate Anxiety (GAD-7 score 10-14)

Offer CBT as first-line treatment 1, 5, 6:

• CBT delivered by a trained therapist (psychologist, licensed counselor, or social worker) is the gold-standard psychological intervention with the strongest evidence base 1, 4, 5
• Typical course: 12-16 weekly sessions, though brief CBT (6-8 sessions) in primary care settings has demonstrated effectiveness 4, 7
• Core components include: cognitive restructuring (identifying and challenging anxious thoughts), behavioral activation, exposure to feared situations, relaxation training, and relapse prevention 3, 4

Alternative: If CBT is unavailable or the patient prefers medication, consider starting an SSRI 5, 6:

• First-line SSRIs: sertraline, escitalopram, paroxetine, or fluoxetine
• Starting doses: sertraline 25-50 mg daily, escitalopram 5-10 mg daily
• Warn patients that anxiety may temporarily worsen in the first 1-2 weeks before improvement begins at 4-6 weeks 6
• Full therapeutic effect typically requires 8-12 weeks 6

Severe Anxiety (GAD-7 score ≥15) or Significant Functional Impairment

Recommend combined treatment with both CBT and an SSRI 1, 5, 8:

• Combination therapy has superior outcomes compared to monotherapy for severe presentations 8
• Start SSRI immediately while arranging CBT referral
• SNRIs (venlafaxine extended-release 37.5-75 mg daily, or duloxetine 30-60 mg daily) are acceptable alternatives if SSRIs are contraindicated or previously ineffective 1, 5, 6

Critical Red Flags Requiring Immediate Psychiatric Referral

Refer urgently to psychiatry or emergency services if:

• Active suicidal ideation with plan or intent
• Severe agitation or inability to function
• Psychotic symptoms (hallucinations, delusions)
• Confusion or delirium 3, 2

Medication Management Specifics

What NOT to Prescribe

Avoid benzodiazepines (alprazolam, lorazepam, clonazepam) for new-onset anxiety in a 22-year-old 3:

• High risk of dependence and abuse, particularly in young adults
• Cognitive impairment and sedation
• Withdrawal difficulties
• Only consider for very short-term use (days to 2 weeks maximum) while awaiting SSRI effect, and only if symptoms are severely disabling 3, 7

SSRI/SNRI Prescribing Considerations

When choosing between medications, consider 3:

• Side effect profiles: SSRIs commonly cause initial nausea, headache, sexual dysfunction; SNRIs may add increased blood pressure, sweating 1
• Drug interactions: Check current medications
• Patient preference: Discuss daily medication versus as-needed options
• Cost and insurance coverage

Monitor closely 3:

• Assess monthly until symptoms stabilize
• Screen for treatment adherence, side effects, and suicidal ideation (FDA black box warning for patients <25 years)
• If no improvement after 8 weeks at therapeutic dose, consider switching medications or adding CBT 3
• Continue medication for at least 12 months after symptom remission before considering taper 3

Follow-Up Strategy

Structured reassessment is critical because patients with anxiety often avoid follow-through on referrals 3:

• Monthly contact (in-person or phone) until symptoms improve
• Repeat GAD-7 at each visit to track progress objectively
• Assess compliance with therapy appointments and medication
• Address barriers to treatment (cost, transportation, stigma, side effects)
• If poor response after 8 weeks despite good adherence, modify the treatment plan: switch medications, add CBT to medication, or increase therapy intensity 3

Collaborative Care Model

If available in your practice, utilize Collaborative Care Management 7:

• Involves primary care clinician, consulting psychiatrist, and care manager
• Care manager monitors symptoms, provides brief behavioral interventions, facilitates treatment adjustments
• This model significantly improves anxiety outcomes compared to usual care 7

Common Pitfalls to Avoid

1. Failing to screen systematically: Use GAD-7 routinely rather than relying on spontaneous patient report 1, 2
2. Prescribing benzodiazepines as first-line: This creates dependence without addressing underlying pathology 3, 7
3. Inadequate SSRI dosing or duration: Many patients receive subtherapeutic doses or discontinue prematurely 3
4. Not addressing comorbidities: Screen for depression (PHQ-9), substance use, and ADHD, which commonly co-occur 1, 9
5. Assuming all anxiety is GAD: Consider panic disorder, social anxiety, or specific phobias, which may require tailored approaches 1